Clinical trial
PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial
NCT04360720 is registered in ClinicalTrials.gov with Hospital Israelita Albert Einstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial
- Lead sponsor
- Hospital Israelita Albert Einstein
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 15, 2020
- Completion date
- December 30, 2024
- Enrollment
- 3,410 (actual)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.